德国生物科技公司Evotec SE周一盘前股价大涨24.21%,创下近四年来最大单日涨幅。这主要是因为传出私募股权公司Triton Partners正在考虑收购该公司所致。
据知情人士透露,Triton一直在寻求与Evotec高管会面,以探讨潜在收购事宜。Triton近期通过一系列交易,将其在Evotec的股份比例提高到9.99%,成为后者的最大单一股东之一。
如果Triton真的有意斥巨资收购Evotec并最终成功,那么这无疑将引发公司控制权的转移。不过,知情人士表示,审议仍在进行中,Triton仍有可能决定不提出任何正式要约。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.